CC•benzinga•
Chemours Expects FY25 Adjusted EBITDA Of $825M - $975M, Capital Expenditures Of $250M - $300M
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 18, 2025 by benzinga